I've been involved in a lot of discussion recently on AKI and CKD and we keep coming round to agreeing that creatinine's are terrible and all would be well (or at least better ) if we used enzymic tests. The eGFR fiasco taught is that if nothing else and we have good evidence of poor dosing in chemotherapy etc, etc.
I'm also told we can't do this because enzymic test are expensive.
But hold on, we do glucose by enzymic methods and that's cheap as chips so why is creatinine more expensive.
Surely at the volumes we do in the UK the prices should be similar so where is the extra cost incurred.
Anyone have a view or an explanation?
Rick
Dr Rick Jones
Sen Lect, Yorkshire Centre Health Informatics, Univ of Leeds Consultant Chemical Pathologist, Leeds Teaching Hospitals NHS Trust
NHS England, National Pathology Programme, Pathology IT Advisor
[log in to unmask]
W: www.ychi.leeds.ac.uk/rgjones
T: 0113 343 4961
M: 07976 743 549
------ACB discussion List Information--------
This is an open discussion list for the academic and clinical community working in clinical biochemistry.
Please note, archived messages are public and can be viewed via the internet. Views expressed are those of the individual and they are responsible for all message content.
ACB Web Site
http://www.acb.org.uk
Green Laboratories Work
http://www.laboratorymedicine.nhs.uk
List Archives
http://www.jiscmail.ac.uk/lists/ACB-CLIN-CHEM-GEN.html
List Instructions (How to leave etc.)
http://www.jiscmail.ac.uk/
|